mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2020-2-7-13mrj-1007Research ArticleЛЕКЦИИLECTURESОценка статуса больных ревматоидным артритом. Современные тенденцииAssessing the status of patients with rheumatoid arthritis: modern tendenciesЛилаА. М.LilaA. M.

Александр Михайлович Лила

115522, Москва, Каширское шоссе, 34А125993, Москва, ул. Баррикадная, 2/1, стр. 1 

Aleksandr Mikhailovich Lila

34A, Kashirskoe Shosse, Moscow 1155222/1, Barrikadnaya St., Build. 1, Moscow 125993 

amlila@mail.ruОлюнинЮ. А.OlyuninYu. A.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

ГордеевА. В.GordeevA. V.

125993, Москва, ул. Баррикадная, 2/1, стр. 1

2/1, Barrikadnaya St., Build. 1, Moscow 125993

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»; кафедра ревматологии ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияV.A. Nasonova Research Institute of Rheumatology; Department of Rheumatology, Russian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaRussian FederationФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian Federationкафедра ревматологии ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава РоссииРоссияDepartment of Rheumatology, Russian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaRussian Federation202029052020142713Copyright © Лила А.М., Олюнин Ю.А., Гордеев А.В., 20202020Лила А.М., Олюнин Ю.А., Гордеев А.В.Lila A.M., Olyunin Y.A., Gordeev A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/1007

Оценка статуса больного ревматоидным артритом позволяет получить информацию, необходимую для выбора адекватной тактики ведения пациента. Использование в рутинной практике количественных методов определения воспалительной активности является основой для разработки стандартизированных рекомендаций по ведению больных и обеспечивает существенное повышение качества медицинской помощи. Вместе с тем накопленный опыт свидетельствует о том, что имеющиеся суммарные индексы не всегда позволяют корректно определить активность заболевания. В статье обсуждаются факторы, способные исказить результат оценки воспалительной активности, а также подходы к устранению возможных ошибок.

Assessing the status of a patient with rheumatoid arthritis allows one to obtain information necessary to choose appropriate management tactics for the patient. The use of quantitative methods in routine practice to determine inflammatory activity is the basis for the development of standardized patient management recommendations and provides a substantial improvement in the quality of health care. At the same time, the accumulated experience suggests that the existing summary indices do not always allow one to correctly determine disease activity. The paper discusses factors that can corrupt the result of assessment of inflammatory activity, as well as approaches to eliminating possible errors.

ревматоидный артритоценка активностисуммарные индексы активностиневропатическая болькоморбидные заболеванияrheumatoid arthritisactivity assessmenttotal activity indicesneuropathic paincomorbid diseasesReferencesЗинчук ИЮ, Амирджанова ВН. Социальное бремя ревматоидного артрита. Научно-практическая ревматология. 2014;52(3):331-5. doi: 10.14412/1995-4484-2014331-335Zinchuk IYu, Amirdzhanova VN. Social burden of rheumatoid arthritis. Nauchnoprakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(3):331-5. (In Russ.). doi: 10.14412/1995-4484-2014331-335Насонов ЕЛ, Лила АМ. Ингибиторы Янус-киназ при иммуновоспалительных ревматических заболеваниях: новые возможности и перспективы. Научно-практическая ревматология. 2019;57(1):8-16. doi: 10.14412/1995-4484-2019-8-16Nasonov EL, Lila AM. Janus kinase inhibitors in immuno-inflammatory rheumatic diseases: new opportunities and prospects. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2019;57(1):8-16 (In Russ.). doi: 10.14412/1995-4484-2019-8-16Насонов ЕЛ, Олюнин ЮА, Лила АМ. Ревматоидный артрит: проблемы ремиссии и резистентности к терапии. Научнопрактическая ревматология. 2018;56(3):263-71. doi: 10.14412/1995-4484-2018263-271Nasonov EL, Olyunin YuA, Lila AM. Rheumatoid arthritis: the problems of remission and therapy resistance. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2018;56(3):263-71. (In Russ.). doi: 10.14412/1995-4484-2018263-271Олюнин ЮА. Оценка боли при ревматоидном артрите. Практическая значимость. Современная ревматология. 2019;13(1):121-8. doi: 10.14412/1996-7012-20191-121-128Olyunin YuA. Assessment of pain in rheumatoid arthritis. Practical significance. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2019;13(1):121-8. (In Russ.). doi: 10.14412/1996-7012-20191-121-128Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis2019-216655. doi: 10.1136/annrheumdis2019-216655 [Epub ahead of print].Smolen JS, Landewe RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis2019-216655. doi: 10.1136/annrheumdis2019-216655 [Epub ahead of print].England BR, Tiong BK, Bergman MJ, et al. 2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures. Arthritis Care Res (Hoboken). 2019 Dec;71(12): 1540-55. doi: 10.1002/acr.24042England BR, Tiong BK, Bergman MJ, et al. 2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures. Arthritis Care Res (Hoboken). 2019 Dec;71(12): 1540-55. doi: 10.1002/acr.24042Olofsson T, Söderling JK, Gü lfe A, et al. Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018 Nov;70(11): 1712-6. doi: 10.1002/acr.23619Olofsson T, Söderling JK, Gü lfe A, et al. Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2018 Nov;70(11): 1712-6. doi: 10.1002/acr.23619Rydholm M, Wikström I, Hagel S, et al. The Relation Between Disease Activity, Patient-Reported Outcomes, and Grip Force Over Time in Early Rheumatoid Arthritis. ACR Open Rheumatol. 2019 Aug 19;1(8): 507-15. doi: 10.1002/acr2.11062.Rydholm M, Wikström I, Hagel S, et al. The Relation Between Disease Activity, Patient-Reported Outcomes, and Grip Force Over Time in Early Rheumatoid Arthritis. ACR Open Rheumatol. 2019 Aug 19;1(8): 507-15. doi: 10.1002/acr2.11062.Liff MH, Hoff M, Fremo T, et al. Cardiorespiratory fitness in patients with rheumatoid arthritis is associated with the patient global assessment but not with objective measurements of disease activity. RMD Open. 2019 Apr 20;5(1):e000912. doi: 10.1136/rmdopen-2019-000912Liff MH, Hoff M, Fremo T, et al. Cardiorespiratory fitness in patients with rheumatoid arthritis is associated with the patient global assessment but not with objective measurements of disease activity. RMD Open. 2019 Apr 20;5(1):e000912. doi: 10.1136/rmdopen-2019-000912Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51): S35-61.Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51): S35-61.Challa DNV, Crowson CS, Davis JM 3rd. The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors. Rheumatol Ther. 2017 Jun;4(1):201-8. doi: 10.1007/s40744-017-0063-5Challa DNV, Crowson CS, Davis JM 3rd. The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors. Rheumatol Ther. 2017 Jun;4(1):201-8. doi: 10.1007/s40744-017-0063-5Molenaar ET, Voskuyl AE, Dinant HJ, et al. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. 2004 Jan;50(1):36-42.Molenaar ET, Voskuyl AE, Dinant HJ, et al. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. 2004 Jan;50(1):36-42.Markusse IM, Dirven L, Gerards AH, et al. Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study. Arthritis Res Ther. 2015 Aug 31;17:232. doi: 10.1186/s13075-015-0730-2Markusse IM, Dirven L, Gerards AH, et al. Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study. Arthritis Res Ther. 2015 Aug 31;17:232. doi: 10.1186/s13075-015-0730-2Bechman K, Tweehuysen L, Garrood T, et al. Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes. J Rheumatol. 2018 Nov;45(11):1515-21. doi: 10.3899/jrheum.171375Bechman K, Tweehuysen L, Garrood T, et al. Flares in Rheumatoid Arthritis Patients with Low Disease Activity: Predictability and Association with Worse Clinical Outcomes. J Rheumatol. 2018 Nov;45(11):1515-21. doi: 10.3899/jrheum.171375McWilliams DF, Rahman S, James RJE, et al. Disease activity flares and pain flares in an early rheumatoid arthritis inception cohort; characteristics, antecedents and sequelae. BMC Rheumatol. 2019 Nov 18;3:49. doi: 10.1186/s41927-019-0100-9McWilliams DF, Rahman S, James RJE, et al. Disease activity flares and pain flares in an early rheumatoid arthritis inception cohort; characteristics, antecedents and sequelae. BMC Rheumatol. 2019 Nov 18;3:49. doi: 10.1186/s41927-019-0100-9Каратеев АЕ, Насонов ЕЛ. Хроническая боль и центральная сенситизация при иммуновоспалительных ревматических заболеваниях: патогенез, клинические проявления, возможность применения таргетных базисных противовоспалительных препаратов. Научно-практическая ревматология. 2019;57(2):197-209. doi: 10.14412/1995-4484-2019-197-209Karateev AE, Nasonov EL. Chronic pain and central sensitization in immuno-inflammatory rheumatic diseases: pathogenesis, clinical manifestations, the possibility of using targeted disease modifying antirheumatic drugs. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2019;57(2):197-209. (In Russ.). doi: 10.14412/1995-4484-2019-197-209Филатова ЕС, Туровская ЕФ, Алексеева ЛИ и др. Анализ патогенетических механизмов хронической суставной боли у больных ревматоидным артритом и остеоартрозом коленных суставов. Научно-практическая ревматология. 2014;52(6):631-5. doi: 10.14412/1995-4484-2014-631-635Filatova ES, Turovskaya EF, Alekseeva LI, et al. Analysis of the pathogenetic mechanisms of chronic joint pain in patients with rheumatoid arthritis and knee osteoarthritis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2014;52(6):631-5. (In Russ.). doi: 10.14412/1995-4484-2014-631-635Noda K, Tajima M, Oto Y, et al. How do neuropathic pain-like symptoms affect health-related quality of life among patients with rheumatoid arthritis?: A comparison of multiple pain-related parameters. Mod Rheumatol. 2019 Aug 9:1-7. doi: 10.1080/14397595.2019.1650462 [Epub ahead of print].Noda K, Tajima M, Oto Y, et al. How do neuropathic pain-like symptoms affect health-related quality of life among patients with rheumatoid arthritis?: A comparison of multiple pain-related parameters. Mod Rheumatol. 2019 Aug 9:1-7. doi: 10.1080/14397595.2019.1650462 [Epub ahead of print].Luque Ramos A, Redeker I, Hoffmann F, et al. Comorbidities in Patients with Rheumatoid Arthritis and Their Association with Patient-reported Outcomes: Results of Claims Data Linked to Questionnaire Survey. J Rheumatol. 2019 Jun;46(6):564-71. doi: 10.3899/jrheum.180668Luque Ramos A, Redeker I, Hoffmann F, et al. Comorbidities in Patients with Rheumatoid Arthritis and Their Association with Patient-reported Outcomes: Results of Claims Data Linked to Questionnaire Survey. J Rheumatol. 2019 Jun;46(6):564-71. doi: 10.3899/jrheum.180668Лила АМ, Гордеев АВ, Олюнин ЮА, Галушко ЕА. Мультиморбидность в ревматологии. От комплексной оценки болезни – к оценке комплекса болезней. Современная ревматология. 2019;13(3):4-9. doi: 10.14412/1996-7012-2019-3-4-9Lila AM, Gordeev AV, Olyunin YuA, Galushko EA. Multimorbidity in rheumatology. From comprehensive assessment of disease to evaluation of a set of diseases. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2019;13(3):4-9. (In Russ.). doi: 10.14412/1996-7012-2019-3-4-9Абрамкин АА, Лисицына ТА, Вельтищев ДЮ и др. Факторы, влияющие на эффективность терапии у больных ревматоидным артритом: роль коморбидной психической и соматической патологии. Научно-практическая ревматология. 2018;56(4):439-48. doi: 10.14412/1995-4484-2018-439-48Abramkin AA, Lisitsyna TA, Vel'tishchev DYu, et al. Factors influencing the efficiency of therapy in patients with rheumatoid arthritis: the role of comorbid mental and somatic diseases. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2018; 56(4):439-48. (In Russ.). doi: 10.14412/1995-4484-2018-439-48Baillet A, Gossec L, Carmona L, et al. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis. 2016 Jun;75(6):965-73. doi: 10.1136/annrheumdis-2016-209233Baillet A, Gossec L, Carmona L, et al. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis. 2016 Jun;75(6):965-73. doi: 10.1136/annrheumdis-2016-209233Radner H, Chatzidionysiou K, Nikiphorou E, et al. 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis. Ann Rheum Dis. 2018 Apr;77(4):476-9. doi: 10.1136/annrheumdis-2017-212256Radner H, Chatzidionysiou K, Nikiphorou E, et al. 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis. Ann Rheum Dis. 2018 Apr;77(4):476-9. doi: 10.1136/annrheumdis-2017-212256

The authors declare that there are no conflicts of interest present.